Scotland · NHS Scotland MSAN
Selegiline (Eldepryl®) 5mg and 10mg tablets
MSAN(2023)1 · Level 2 · issued 16 Jan 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Selegiline (Eldepryl®) 5mg and 10mg tablets are out of stock until April 2023. | Out of stock | April 2023 |
| 2. Rasagiline 1mg tablets remain available and can support a full uplift in demand. | Available | — |
| 3. Selegiline oral suspensions are available via specials manufacturers. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2023:1
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
7d0ec4e88931333f8f3fb37aa3614efbf5461a41e99b0bb5328e5f4c95fb9b06sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2023-01.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.